GLP-1 Therapy Reduces Migraine Frequency by More Than Half in Obesity Patients
A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half
Read the full articleYou might also wanna read
Real-world study suggests GLP-1 receptor agonists may reduce emergency visits and medication needs for chronic migraine
Real-world data suggest GLP-1 receptor agonists may reduce emergency care visits and the need for additional migraine treatments in adults w
mdsc.pe·7d ago
New GLP-1 Drug Promotes Weight Loss in Obesity
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to an 11 percent reduction in body
Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?
Dr. Tesha Monteith discusses the Brain & Life article, "Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?" by Hallie Le
Study links GLP-1 treatment to fewer alcohol drinking days
Current GLP-1 receptor agonist prescriptions were associated with modestly lower AUDIT-C scores in a large, diverse US cohort. The differenc
GLP-1 drugs tied to elevated risk of low blood pressure episodes
Study of 42,000 adults taking blood pressure meds found increased rates of hypotension, dizziness and fainting
Oral small-molecule GLP-1 RA improves blood glucose and weight reduction
The VISTA and SOLSTICE phase 2b trials evaluated the use of the glucagon-like peptide-1 receptor agonist (GLP-1 RA) elecoglipron in adults.
Comments
Sign in to join the conversation.
No comments yet. Be the first.